---
schema_version: "secwatch.filing_event.v1"
accession: "0001174947-23-000616"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2023-04-26T23:59:59+00:00"
generated_at: "2026-06-16T14:36:18.429424+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q1 sales $295.5M (+21.9% YoY); raises FY 2023 revenue and EPS guidance

## Summary
- Sales $295.5M (+21.9% as reported; +25.1% constant currency); acquisitions contributed ~570 bps growth.
- GAAP diluted EPS $0.06 (down 87.2% YoY); adjusted diluted EPS $0.66 (down 5.7% YoY).
- Raises FY 2023 revenue guidance to $1.205B-$1.250B from $1.170B-$1.220B.
- Raises FY 2023 adjusted EPS guidance to $3.30-$3.50 from $3.20-$3.45.
- Adjusted EBITDA $51.2M (17.3% margin) vs $43.7M (18.0% margin) in Q1 2022.

## SEC filing metadata
- accession: 0001174947-23-000616
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2023-04-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/0001174947-23-000616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/form8k-30039_cnmd.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001174947-23-000616
- JSON: https://secwatch.observer/filing/0001174947-23-000616.json
- Plain text: https://secwatch.observer/filing/0001174947-23-000616.txt

## Key facts
- Earnings Releases
  CONMED Corp reported the full year 2023 results: revenue between $1.205 billion and $1.250 billion, EPS in the range of $3.30 to $3.50. Guidance raised.
  - Period: the full year 2023
  - Revenue: between $1.205 billion and $1.250 billion
  - EPS: in the range of $3.30 to $3.50
  - Guidance: raised
  - Result: guidance update
  source text: Based on the first quarter results, the Company is raising its revenue guidance for the full year 2023 and now expects revenue between $1.205 billion and $1.250 billion, compared to its prior guidance of between $1.170 billion and $1.220 billion.
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/0001174947-23-000616-index.htm
- Earnings Releases
  CONMED Corp reported the first quarter ended March 31, 2023 results: revenue $295.5 million, EPS $0.06.
  - Period: the first quarter ended March 31, 2023
  - Revenue: $295.5 million
  - EPS: $0.06
  - Result: reported results
  source text: Florida, April 26, 2023 – CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2023. First Quarter 2023 Highlights · Sales of $295.5 million increased 21.9% year over year as reported and 25.1% in constant currency. Acquisitions contributed approximately 570 basis points of growth. · Domestic revenue increased 25.4%
  evidence_url: https://www.sec.gov/Archives/edgar/data/816956/000117494723000616/0001174947-23-000616-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.